No differences were observed between SSc-ILD and SSc-No ILD patients in the percentage of total circulating CD14+ cells (6.68 ± 1.8% and 7.57 ± 2.5%, respectively, p = 0.18). The gene discussed is CD14; the disease is interstitial lung disease.